Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 56 studies with search of: | "Amprenavir" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir
|
||||
2 | Completed |
An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
|
||||
3 | Completed |
A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir
|
||||
4 | Completed |
A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
|
||||
5 | Completed |
A Study of Amprenavir in HIV-Infected Patients
|
||||
6 | Completed |
A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients
|
||||
7 | Completed |
A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications
|
||||
8 | Active, not recruiting |
Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
|
||||
9 | Completed |
Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz
|
||||
10 | Completed |
Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.
|
||||
11 | Completed |
A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients
|
||||
12 | Completed |
Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers
|
||||
13 | Completed |
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
|
||||
14 | Completed |
Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
|
||||
15 | Completed |
A Study of 141W94 in Combination With Other Anti-HIV Drugs
|
||||
16 | Active, not recruiting |
Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment
|
||||
17 | Completed |
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
|
||||
18 | Completed |
A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection
|
||||
19 | Completed |
A Comparison of 141W94 and Indinavir in HIV-Infected Patients
|
||||
20 | Completed |
The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |